Acasti Pharma IncKapitalflussrechnung
| Preis (2024-10-25) | 52W Hoch | 52W Tief |
| 3.37 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 1,96 USD | 1 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 10.139.900 | 1,93 | 3,84 |
Kennzahl in 1000 USD | TTM 2023-03-31 | 2022-03-31 | 2021-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - | - |
Cashflow aus operativer Geschäftstätigkeit | - | - | - | - | - | - | - | - | - |
▸ Operative Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Investitionsausgaben (CapEx) | - | - | - | - | - | - | - | - | - |
Cashflow aus Investitionstätigkeit | - | - | - | - | - | - | - | - | - |
Cashflow aus Finanzierungstätigkeit | - | - | - | - | - | - | - | - | - |
Freier Cashflow | - | - | - | - | - | - | - | - | - |
▸ Freie Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - |